Patent assignee · US · COMPANY

Veracyte, Inc.

🏢 View company profile →
18Patents
18Active
18Granted
50Portfolio score

Filing activity: Nov 17, 2009 → Sep 23, 2024 · 3 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8541170B2 Methods and compositions of molecular profiling for disease diagnostics Chemistry; Metallurgy 48 Active
US9495515B1 Algorithms for disease diagnostics Physics 41 Active
US8669057B2 Methods and compositions for diagnosis of thyroid conditions Emerging Cross-Sectional Technologies 26 Active
US9856537B2 Algorithms for disease diagnostics Physics 24 Active
US10731223B2 Algorithms for disease diagnostics Physics 23 Active
US10114924B2 Methods for processing or analyzing sample of thyroid tissue Emerging Cross-Sectional Technologies 20 Active
US10236078B2 Methods for processing or analyzing a sample of thyroid tissue Emerging Cross-Sectional Technologies 11 Active
US10446272B2 Methods and compositions for classification of samples Emerging Cross-Sectional Technologies 10 Active
US10672504B2 Algorithms for disease diagnostics Emerging Cross-Sectional Technologies 8 Active
US10526655B2 Methods for evaluating COPD status Physics 6 Active
US10934587B2 Methods and compositions for diagnosis of thyroid conditions Emerging Cross-Sectional Technologies 5 Active
US11217329B1 Methods and systems for determining biological sample integrity Chemistry; Metallurgy 5 Active
US12110554B2 Methods for classification of tissue samples as positive or negative for cancer Emerging Cross-Sectional Technologies 2 Active
US11976329B2 Methods and systems for detecting usual interstitial pneumonia Physics 0 Active
US12297503B2 Methods for classification of tissue samples as positive or negative for cancer Emerging Cross-Sectional Technologies 0 Active
US12297505B2 Algorithms for disease diagnostics Physics 0 Active
US11639527B2 Methods for nucleic acid sequencing Chemistry; Metallurgy 0 Active
US12305238B2 Methods for treatment of thyroid cancer Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.